| http://dbpedia.org/ontology/abstract
|
Atidarsagene autotemcel, sold under the br … Atidarsagene autotemcel, sold under the brand name Libmeldy, is a gene therapy treatment for metachromatic leukodystrophy (MLD) developed by . It contains an autologous CD34⁺ cell enriched population that contains haematopoietic stem and progenitor cells transduced using a lentiviral vector encoding the human arylsulfatase A (ARSA) gene. Atidarsagene autotemcel was approved for medical use in the European Union in December 2020, and in the United Kingdom in February 2021.nd in the United Kingdom in February 2021.
|
| http://dbpedia.org/ontology/alternativeName
|
Libmeldy
|
| http://dbpedia.org/ontology/fdaUniiCode
|
EPP8G99QG4
|
| http://dbpedia.org/ontology/wikiPageID
|
68874796
|
| http://dbpedia.org/ontology/wikiPageLength
|
7176
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123004717
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Gene_therapy +
, http://dbpedia.org/resource/Intravenous_infusion +
, http://dbpedia.org/resource/Hematopoietic_stem_cell +
, http://dbpedia.org/resource/BeneluxA +
, http://dbpedia.org/resource/Autologous +
, http://dbpedia.org/resource/Metachromatic_leukodystrophy +
, http://dbpedia.org/resource/CD34%E2%81%BA +
, http://dbpedia.org/resource/Orchard_Therapeutics +
, http://dbpedia.org/resource/Arylsulfatase_A +
, http://dbpedia.org/resource/NHS_England +
, http://dbpedia.org/resource/Gene_therapy +
, http://dbpedia.org/resource/Lentiviral_vector +
, http://dbpedia.org/resource/Biallelic +
|
| http://dbpedia.org/property/atcPrefix
|
A16
|
| http://dbpedia.org/property/atcSuffix
|
AB21
|
| http://dbpedia.org/property/legalEu
|
Rx-only
|
| http://dbpedia.org/property/legalUk
|
POM
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Intravenous_infusion +
|
| http://dbpedia.org/property/synonyms
|
OTL-200
|
| http://dbpedia.org/property/tradename
|
Libmeldy
|
| http://dbpedia.org/property/unii
|
EPP8G99QG4
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Portal_bar +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Gene_therapy +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Atidarsagene_autotemcel?oldid=1123004717&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Atidarsagene_autotemcel +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q108887202 +
, http://dbpedia.org/resource/Atidarsagene_autotemcel +
, https://global.dbpedia.org/id/G7MVX +
|
| rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
| rdfs:comment |
Atidarsagene autotemcel, sold under the br … Atidarsagene autotemcel, sold under the brand name Libmeldy, is a gene therapy treatment for metachromatic leukodystrophy (MLD) developed by . It contains an autologous CD34⁺ cell enriched population that contains haematopoietic stem and progenitor cells transduced using a lentiviral vector encoding the human arylsulfatase A (ARSA) gene. Atidarsagene autotemcel was approved for medical use in the European Union in December 2020, and in the United Kingdom in February 2021.nd in the United Kingdom in February 2021.
|
| rdfs:label |
Atidarsagene autotemcel
|
